Free Access
| Issue |
Med Sci (Paris)
Volume 40, Number 6-7, Juin-Juillet 2024
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 573 - 575 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2024073 | |
| Published online | 08 July 2024 | |
- Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res 2019 ; 79 : 4557–4566. [CrossRef] [Google Scholar]
- Jorgovanovic D, Song M, Wang L, et al. Roles of IFN-γ in tumor progression and regression: a review. Biomarker Research 2020; 8 : 49. [CrossRef] [PubMed] [Google Scholar]
- Chen Y, Du M, Yuan Z, et al. Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy. Nat Commun 2022; 13 : 4468. [CrossRef] [PubMed] [Google Scholar]
- Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 2010 ; 10 : 785–794. [CrossRef] [PubMed] [Google Scholar]
- Kasinskas RW, Forbes NS. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 2006 ; 94 : 710–721. [CrossRef] [PubMed] [Google Scholar]
- Wu MR, Jusiak B, Lu TK. Engineering advanced cancer therapies with synthetic biology. Nat Rev Cancer 2019 ; 19 : 187–195. [PubMed] [Google Scholar]
- Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A 1999 ; 96 : 1639–1644. [CrossRef] [PubMed] [Google Scholar]
- Duong MT-Q, Qin Y, You S-H, et al. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp Mol Med 2019; 51 : 1–15. [CrossRef] [PubMed] [Google Scholar]
- Malley BW, Li D, McQuone SJ, et al. Combination Nonviral Interleukin-2 Gene Immunotherapy For Head and Neck Cancer: From Bench Top to Bedside. Laryngoscope 2005 ; 115 : 391–404. [CrossRef] [PubMed] [Google Scholar]
- Abedi MH, Yao MS, Mittelstein DR, et al. Ultrasound-controllable engineered bacteria for cancer immunotherapy. Nat Commun 2022; 13 : 1585. [CrossRef] [PubMed] [Google Scholar]
- Dróżdż M, Makuch S, Cieniuch G, et al. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications. Life Sciences 2020; 261 : 118296. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.